Hubert Czerniak - Wyjątkowa substancja prosto od natury! Bogactwo składników na poprawę odporności!

Czerniak emphasized that colostrum’s primary value lies in programming the immune system and nurturing a healthy microbiome. For prophylaxis, short intermittent courses are sufficient to re-seed the gut with beneficial signals. He recommended lyophilized bovine colostrum as it is three times more active than dried forms. He noted that even in the absence of acute issues, adult guts can become ‘leaky’ or inflamed from modern diets, so periodic reinforcement helps maintain the anti-inflammatory SCFA profile. The dosing is modest compared to therapeutic protocols, reflecting a maintenance approach.

He distinguished this from prophylaxis by the extended duration and slightly higher dose. The logic is that established gut dysfunction requires a steady supply of colostrum components to shift the microbiome balance toward the anti-inflammatory green bacteria and to physically seal the gut lining. He linked it to the ‘beetroot test’ for intestinal permeability, implying that after such a course, gut integrity should improve measurably.

Czerniak stressed that antibiotics not only kill pathogens but also decimate the beneficial bacteria responsible for producing anti-inflammatory SCFAs. A short probiotic course is insufficient; colostrum offers both prebiotic substrates (oligosaccharides) and immune factors that guide the reassembly of a healthy microbiome. The extended timeline (6–12 months) reflects the observation that full microbiome recovery is slow. He did not specify an exact daily dose post-antibiotics, but the context suggests using the therapeutic dose of 2–4 capsules daily from the gut protocol.

Czerniak presented this as a comprehensive adjunct protocol, urging patients not to fear using vitamins alongside conventional treatment. He argued that the cancer cell’s metabolic inflexibility (reliance on glycolysis) means it cannot benefit from mitochondrial-supporting nutrients, while healthy cells can regenerate faster. He also recommended applying DMSO to the skin areas being irradiated to reduce damage. He reiterated that gut flora will be decimated, so colostrum and Narine are necessary to repopulate and repair the intestinal lining. This protocol is aggressive and reflects his view that cancer therapy is excessively toxic and needs aggressive nutritional countermeasures.

Czerniak introduced butyrate supplementation as an immediate intervention while colostrum works to rebuild the flora that naturally produces it. He stressed that in severe gut inflammation, waiting for the microbiome to recover is inadequate; exogenous butyrate can directly engage the anti-inflammatory receptors he described earlier. The dosing for Crohn’s is four times higher than the standard, reflecting the severity of the condition. He assured the audience that butyrate is merely a short-chain fatty acid, so overdosing will not cause toxicity, though high doses might cause loose stools.

Czerniak walked through a diagram showing that butyrate binds to the receptor GPR109a on colon macrophages and dendritic cells, activating their anti-inflammatory properties and inhibiting both inflammation and cancer development. Simultaneously, butyrate engages GPR43 and GPR41 to regulate the production of cathelicidin, a peptide he described as an 'intelligent antibiotic' that modifies its structure as viruses and bacteria evolve to evade the immune system. He connected this to vitamin D3, which also stimulates cathelicidin, implying a synergistic network where colostrum-supplied prebiotics foster butyrate-producing flora, which in turn boosts innate immunity through cathelicidin. This mechanism, he argued, explains why colostrum is beneficial in all inflammatory and infectious conditions, as it promotes the flora that generates the anti-inflammatory and antimicrobial signaling molecules.

He asserted that the vitamins listed (C, A, D, E, K, B complex) are needed in large amounts during radical cancer treatments because they accelerate the regeneration of healthy cells. His argument hinges on the Warburg effect: cancer cells primarily use glycolysis for energy, not the Krebs cycle within mitochondria, so vitamins that support mitochondrial function will selectively aid healthy cells without fueling the tumor. He also recommended simultaneously taking colostrum to regenerate the gut flora that is destroyed by therapy, along with Narine probiotic bacteria, drinking DMSO, and applying a 50–70% DMSO solution to the irradiated skin area. He urged the audience not to be afraid of this approach, framing it as essential support for the body during harsh conventional treatments.

Czerniak mentioned that Polish researchers have contributed to colostrum science by discovering colostrynine, a protein that inhibits the accumulation of beta-amyloid, the hallmark of Alzheimer’s disease. He stated that this protein delays senile dementia and general cognitive decline, though he did not provide dosage or detailed study data. This positions colostrum not only as a neonatal protector but as a lifelong supplement with potential neuroprotective benefits.

In a closing segment referencing Albert Camus’ "The Plague", Czerniak drew a parallel between historical ignorance and modern trust in authorities. He related a question posed to a doctor about masks: 'Are they helpful?' – the doctor replied 'No, but they build trust in others.' He then asserted that masks cause a drop in arterial oxygen saturation to 80%, and because respiratory failure is diagnosed below 90% saturation, a mask alone can induce respiratory failure. He suggested that this ignorance and blind faith have been 'punished by death', alluding to excess mortality. This served as a segue to his overarching theme that knowledge, such as the detailed science he provided on colostrum, is the best defense.